Furthermore, the newly discovered KIR3DL3-TAFA2 interaction may represent another intriguing way of modulating the KIR3DL3/TMIG2-HHLA2 signaling axis within the tumor microenvironment (Li et al., 2022; Wei et al., 2021). The gene discussed is HHLA2; the disease is neoplasm.